Glycomet Tablet 5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
MFDS item code 202201744 · Approved 2022.04.29
Effectiveness in glycemic control and prevention of cardiovascular events in type 2 diabetes.
This medication helps control blood sugar levels in adults with type 2 diabetes through the combined administration of empagliflozin and metformin. It should be used in conjunction with dietary and exercise therapy to enhance blood sugar management, especially suitable for adult patients whose blood sugar is not adequately controlled. Additionally, patients with confirmed cardiovascular disease require caution regarding the occurrence of cardiovascular events, necessitating reference to clinical trial information from specialists. Overall, this medication effectively improves blood sugar control in patients with type 2 diabetes.
The recommended dosage of this medication is 1 tablet, twice a day. The maximum recommended daily dose for each component should not exceed 25 mg of empagliflozin and 2000 mg of metformin, and is determined based on the patient's current treatment regimen, efficacy, and tolerability. For patients who do not achieve adequate glycemic control with metformin alone or in combination with insulin or other medications, the recommended dosage is 5 mg of empagliflozin twice daily (total daily dose of 10 mg) and the current dose of metformin.
This medication aids in controlling blood sugar. However, there is a risk of rare but serious side effects such as lactic acidosis, which can be dangerous and potentially life-threatening due to excessive lactate accumulation in the body. When taking this medication alongside insulin or other diabetes medications, it is important to closely monitor blood sugar levels, as hypoglycemia may occur. Patients with poor kidney function, severe infections, dehydration, or heart problems should not take this medication. Additionally, this medication should be temporarily discontinued before and after examinations using iodinated contrast agents, restarting only after kidney function has been confirmed as normal. It is also safest for pregnant or breastfeeding women not to take this medication. During treatment, increased urination or urinary and genital infections may occur; if symptoms appear, consult a healthcare provider. Regular checks may also be needed due to the risk of vitamin B12 deficiency. Alcohol consumption may increase the risk of side effects, so it is advisable to avoid it. Elderly patients and those with impaired kidney function should take this medication with particular caution, receiving regular kidney function checks. In cases of surgical procedures or severe acute illness, discontinuation of this medication may also be necessary. Throughout the treatment, attention should be paid to symptoms of hypoglycemia, especially in cases of irregular meals or excessive exercise. If unusual symptoms or side effects are suspected, it is important to consult a physician or pharmacist immediately.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent exposure to air and moisture, and keep it at room temperature between 1°C and 30°C. This helps maintain the medication's effectiveness for a longer time.
White, biconvex oval film-coated tablets with a yellow tint
60 tablets/bottle, 60 tablets/box [(10 tablets/PTP×6)], 10 tablets/box [(10 tablets/PTP×1)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.